top of page

Reining in drug-market middlemen’s ‘rebate’ payments might be complicated

The FL effort is part of a national reconsideration of the power of these benefit managers, including antitrust scrutiny by the FTC.

Work has begun on one of Gov. Ron DeSantis’ priorities for the regular legislative session, due to open in March: constraining pharmacy benefits management companies that control the flow of prescription drugs to individual patients...


bottom of page